Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$60.21 - $77.74 $2.42 Million - $3.13 Million
-40,251 Reduced 85.95%
6,579 $408,000
Q3 2022

Nov 14, 2022

BUY
$72.92 - $99.73 $2.65 Million - $3.63 Million
36,407 Added 349.29%
46,830 $3.42 Million
Q2 2022

Aug 08, 2022

SELL
$84.23 - $147.57 $996,188 - $1.75 Million
-11,827 Reduced 53.16%
10,423 $985,000
Q1 2022

May 16, 2022

BUY
$122.89 - $171.74 $1.92 Million - $2.68 Million
15,619 Added 235.55%
22,250 $3.08 Million
Q4 2021

Mar 03, 2022

BUY
$156.0 - $265.78 $1.03 Million - $1.76 Million
6,631 New
6,631 $1.21 Million
Q2 2021

Aug 16, 2021

SELL
$169.89 - $231.37 $375,626 - $511,559
-2,211 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$143.93 - $207.3 $318,229 - $458,340
2,211 New
2,211 $372,000

Others Institutions Holding HSKA

About HESKA CORP


  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.